DEXLANSOPRAZOLE DR 60 MG CAP

Dexlansoprazole
$4.0638per EA

Strength

60 mg/1

Manufacturer

Endo USA Inc.

NDC

49884014811

Classification

Generic

Dosage Form

CAPSULE, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DEXLANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA202294

On Market Since

11/22/2022

Pharmacological Classes

Proton Pump Inhibitor
Proton Pump Inhibitors

Price History

1W

0.0%

1M

-3.6%

3M

-6.2%

6M

-9.9%

1Y

-13.6%

3Y

-42.7%

5Y

N/A

All

-43.7%